Results 241 to 250 of about 1,956,144 (286)
Some of the next articles are maybe not open access.
Journal of the American Medical Directors Association, 2005
Caring for the elderly nursing home patient has never been more clinically complex or administratively more troublesome. Patients carry with them a greater burden of disease with increasing frailty and vulnerability. More drugs are being used for more problems.
Eric G, Tangalos, Barbara J, Zarowitz
openaire +2 more sources
Caring for the elderly nursing home patient has never been more clinically complex or administratively more troublesome. Patients carry with them a greater burden of disease with increasing frailty and vulnerability. More drugs are being used for more problems.
Eric G, Tangalos, Barbara J, Zarowitz
openaire +2 more sources
Multiple Sclerosis Journal, 1996
As a result of recent therapeutic trials, recombinant Interferon beta (r/FNβ)-1b and-1a as well as Copolymer 1 (COP 1) and to some extent unspecific immunosuppressants have been accepted as partially efficient treatments of relapsing-remitting MS. In view of partially effective single treatments, the question arises if combination of two or even more ...
openaire +3 more sources
As a result of recent therapeutic trials, recombinant Interferon beta (r/FNβ)-1b and-1a as well as Copolymer 1 (COP 1) and to some extent unspecific immunosuppressants have been accepted as partially efficient treatments of relapsing-remitting MS. In view of partially effective single treatments, the question arises if combination of two or even more ...
openaire +3 more sources
Rationale for drug combinations
European Journal of Cancer, 2003No reader of this journal needs to be reminded that real progress in the treatment of solid tumours is hard to achieve. The explosion of scientific knowledge about the metabolism of tumours and the genetic influences that promote or restrict growth will it is hoped lead to the more rationale design of therapeutics, which in future will be more ...
openaire +2 more sources
Combination drug therapy for combined hyperlipidemia
Current Cardiology Reports, 1999Combination therapy for hyperlipidemia, especially combined hyperlipidemia, may have advantages over single drug therapy, affording better improvement in lipoprotein risk factors and possibly better prevention of atherothrombotic events. Although preliminary experience has been gained using treatment combinations of niacin with statins, and fibrates ...
openaire +2 more sources
2013
Antimicrobial combination therapy has a long history. The potential for synergy between two antimicrobial agents has been sought using in vitro techniques such as disk approximation, checkerboard titration, in vitro killing experiments with fixed drug concentrations, through the use of in vitro pharmacodynamic models, through animal models, and through
openaire +1 more source
Antimicrobial combination therapy has a long history. The potential for synergy between two antimicrobial agents has been sought using in vitro techniques such as disk approximation, checkerboard titration, in vitro killing experiments with fixed drug concentrations, through the use of in vitro pharmacodynamic models, through animal models, and through
openaire +1 more source
Drug combinations for visceral leishmaniasis
Current Opinion in Infectious Diseases, 2010Several attempts have been made to combine drugs for treating visceral leishmaniasis, but only recently have effective drugs become available and combinations been tested systematically.Sequential treatments with liposomal amphotericin B followed by miltefosine or paromomycin (as short as 7 days), as well as the concomitant administration of ...
openaire +3 more sources